Millie
your market intelligence analyst
Search Results
10 results
Your search is now limited to «Company News in Infectious Diseases» expert search.
MarketWatch 09/17/2019 06:55
Merck & Co. Inc. said Tuesday the Food and Drug Administration has accepted the biologics license application (BLA) for its V920 investigational vaccine for Ebola Zaire virus. The drugmaker said the FDA also granted priority review for V920. The company said it will base new investigational supply on a combination of leveraging material from production activities at the planned commercial manufacturing site in Germany and new production at a clinical manufacturing site in the U.S. Merck's stock edged up 0.2% in premarket trading. It has gained 7.4% year to date, while the SPDR Health Care Select Sector ETF has tacked on 5.6% and the Dow Jones Industrial Average has advanced 16.1%. Market Pulse Stories are Rapid-fire, short news bursts on st.

Personal Care

Household Products

Business Issues

Trends

Companies - Public

Companies - Venture Funded

Information Technologies

Regions

Job Titles